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Transcription Factor Ctip2 Controls Epidermal Lipid
Metabolism and Regulates Expression of Genes
Involved in Sphingolipid Biosynthesis during Skin
Development
Zhixing Wang1, Jay S. Kirkwood1,2, Alan W. Taylor2, Jan F. Stevens1,2, Mark Leid1,3,4, Gitali Ganguli-Indra1,3
and Arup K. Indra1,3,4,5
The stratum corneum is composed of protein-enriched corneocytes embedded in an intercellular matrix of
nonpolar lipids organized as lamellar layers and giving rise to epidermal permeability barrier (EPB). EPB defects
have an important role in the pathophysiology of skin diseases such as eczema. The transcriptional control of
skin lipid metabolism is poorly understood. We have discovered that mice lacking transcription factor COUP-TF-
interacting protein 2 (Ctip2) exhibit EPB defects including altered keratinocyte terminal differentiation, delayed
skin barrier development, and interrupted neutral lipid distribution in the epidermis. Here we adapted a targeted
lipidomic approach using mass spectrometry and have determined that Ctip2 / mice (germline deletion of the
Ctip2 gene) display altered composition of major epidermal lipids, such as ceramides and sphingomyelins,
compared with wild-type mice at different stages of skin development. Interestingly, expressions of several genes
involved in skin sphingolipid biosynthesis and metabolism were altered in mutant skin. Ctip2 was found to be
recruited to the promoter region of a subset of those genes, suggesting their possible direct regulation by Ctip2.
Our results confirm an important role of Ctip2 in regulating skin lipid metabolism and indicate that profiling of
epidermal sphingolipid could be useful for designing effective strategies to improve barrier dysfunctions.
Journal of Investigative Dermatology (2013) 133, 668–676; doi:10.1038/jid.2012.358; published online 25 October 2012
INTRODUCTION
The exterior layer of skin, the stratum corneum (SC), has a
critical role in skin permeability barrier formation and main-
tenance (Fuchs and Raghavan, 2002; Elias, 2004). It forms a
protective barrier against external stress and environmental
insults. Skin barrier defects are linked with altered levels of
protein(s) involved in keratinocyte terminal differentiation,
cornified envelope crosslinking, as well as formation and
maintenance of skin lipid barrier (Elias and Menon, 1991;
Nemes and Steinert, 1999; Feingold, 2007, 2009). Mammalian
SC contains a large number of lipids such as ceramides (CERs),
sphingomyelins, cholesterols, and fatty acids (Elias and Menon,
1991; Feingold, 2007, 2011; Ishikawa et al., 2010). CERs are
the most abundant lipid types in SC (50% by weight) and can
be divided into at least 11 species (Oda et al., 2008; Ishikawa
et al., 2010). It has been shown that reduced content of CERs
leads to epidermal water loss and skin epidermal dysfunctions
and causes diseases such as atopic dermatitis or eczema
(Imokawa, 2009; Ishikawa et al., 2010). Spingomyelins are
another large group of epidermal sphingolipids, which have
been reported as precursors of CERs (Schmuth et al., 2000;
Uchida et al., 2000; Holleran et al., 2006). Cholesterols and
fatty acids are also major skin lipids, and cholesterol-3-sulfate is
a ubiquitous metabolite of cholesterol, which is involved
in cornified envelope formation by interacting with trans-
glutaminase1 (Nemes et al., 2000).
CER biosynthesis is regulated at multiple levels. Four path-
ways have been reported so far: the de novo pathway, the
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sphingomyelinase pathway, the salvage pathway, and the
exogenous CER-recycling pathway (Kitatani et al., 2008).
In the de novo pathway, serine and fatty acyl-CoA are the
initiators of a series of reactions. CER synthases 1–6 (Lass1–
Lass6) have an important role as each of them has specifi-
cities on synthesizing certain CERs (Mizutani et al., 2009).
Other enzymes such as palmitoyltransferases (Sptlc1-3),
dihydroceramide desaturase (Degs1), and 3-ketodihydro-
sphingosine reductase are also key enzymes in the de novo
pathway (Merrill, 2002). The salvage pathway has been
reported recently as a complex mechanism, commencing as
the catabolism of complex sphingolipids into glucosyl-
ceramide by glucosylceramide synthase (Ugcg) and followed
by the formation of CER by acid beta-glucosidase (Gba2)
(Ogretmen, 2002; Becker, 2004). These CERs can be broken
down into sphingosines by ceramidases (Asah1 and Asah2),
which are reused to produce CERs (Bernardo et al., 1995;
Koch et al., 1996; Li et al., 1998; Tani et al., 2000; Mao and
Obeid, 2008). In the sphingomyelinase pathway, CER is
formed by hydrolysis of sphingomyelins, and the reverse
reaction is controlled by sphingomyelin synthase (Marchesini
and Hannun, 2004). Exogenous short-chain CER can also be
utilized to generate sphingosine, thus leading to the synthesis
of endogenous long-chain CERs (Ogretmen, 2002; Sultan
et al., 2006).
COUP-TF-interacting protein 2 (Ctip2), also known as
Bcl11b, is a C2H2 zinc-finger protein expressed in many
organs and tissues, including developing mouse epidermis
(Avram et al., 2000, 2002; Golonzhka et al., 2008). It has
been reported that Ctip2-null mice exhibit altered epidermal
proliferation and late terminal differentiation, as well as barrier
defects during embryogenesis (Golonzhka et al., 2008). The
barrier defects were correlated with altered surface lipid
distribution in the absence of Ctip2 (Golonzhka et al., 2008).
Liquid chromatography–tandem mass spectrometry (LC/MS/
MS) has been used to characterize CER species in mouse and
human SC (Masukawa et al., 2008; Park et al., 2009; Ishikawa
et al., 2010; Janssens et al., 2011; van Smeden et al., 2011).
Here we adopted the LC/MS/MS methodology to elucidate the
CER containing nonhydroxy fatty acids (N) and sphingosine (S)
[CER (NS)], sphingmyelin, and sphingosine profiles in wild-
type and Ctip2-null (Ctip2 / ) embryonic skin epidermis. The
expression levels of genes encoding various enzymes involved
in sphingolipid metabolism were analyzed by quantitative
real-time reverse-transcriptase PCR (qRT-PCR) and immuno-
blotting in wild-type and Ctip2-null skin. Furthermore, Ctip2
recruitment to the promoter regions of several genes that were
altered in Ctip2 / mice was evaluated by chromatin
immunoprecipitation (ChIP) analyses. Results indicated that
Ctip2 controls sphingolipid metabolism in the developing skin
by directly or indirectly regulating the expression of a subset of
genes involved in the sphingolipid biosynthesis pathways.
RESULTS
Altered profile of sphingolipids in the developing epidermis of
Ctip2-null mice
We hypothesized that impaired epidermal permeability
barrier (EPB) in Ctip2-null (Ctip2 / ) mice could be partly
due to altered skin lipid composition. To determine the lipid
composition of embryonic skin, wild-type and Ctip2-null
epidermis were isolated at different developmental stages,
embryonic day (E) 16.5, E17.5, E18.5, and neonatal (postnatal
day 0, P0). Lipidomic studies were then conducted using the
LC/MS/MS technique, and absolute quantities of the different
skin sphingolipids were analyzed (for details see Materials and
Methods). Both CERs and sphingomyelins were abundant
during mouse skin development, especially during the earlier
stages of skin development (E16.5, E17.5) (Figure 1).
CER C14:0 level remained very low from E16.5–P0.
Long-chain CER C16:0 was the most abundant saturated
CER at E16.5 and was 2-fold higher in the mutant epidermis
compared with wild type (Figure 1a). Significant induction of
CER C18:0 was observed in the E16.5 mutant skin (Figure 1a).
The amount of long-chain CERs (C16:0, C18:0, C20:0, and
C22:0) was very low at E17.5–E18.5, with no discernable
difference observed between wild-type and mutant skin;
however, their quantities were larger at P0, each having
an approximately 2-fold reduction in Ctip2 / skin
(Figure 1b–d). At E17.5 and E18.5, very long-chain CER
C26:0 became the predominant subtype in mouse skin,
modestly reduced at E17.5 and 2-fold decreased at E18.5 in
Ctip2 / skin (Figure 1b and c). Modest decrease of CER
C24:0 was also observed in Ctip2 / epidermis at P0
(Figure 1d). Unsaturated CERs were less abundant com-
pared with saturated CERs in the wild-type epidermis. Long-
chain unsaturated CER C16:1 was significantly reduced
at E16.5 in the mutant epidermis, unaffected at E17.5 and
E18.5, with a 2-fold decrease in P0 mutant epidermis
(Figure 1e–h).
Among saturated sphingomyelins, long-chain sphingo-
myelins C16:0, C20:0, and C22:0 were the most abundant
subtypes in embryonic epidermis at most of the stages, which
were highly induced in mutant skin, especially at E17.5 and
E18.5 (Figure 1j and k). Very long-chain sphingomyelins
(C24:1, C26:1, and C28:1) were also increased in the mutant
skin at E16.5–E18.5. Interestingly, unsaturated sphingomyelins
were less abundant at all developmental stages; however, they
showed the same trend as saturated ones, with a higher
amount in embryonic mutant epidermis. As early as E16.5,
long-chain unsaturated sphingomyelin C24:1 was significantly
elevated in Ctip2 / skin (Figure 1m). Higher quantities
of long-chain sphingomyelins C20:1, C22:1, and C24:1
were noted in the mutant epidermis at E17.5 and E18.5
(Figure 1n and o).
The profiles of sphingosine and sphinganine were also
determined by the LC/MS/MS method. Compared with
CERs and sphingomyelins, the quantity of free sphingoid
bases was smaller in embryonic skin, with no signi-
ficant changes observed between wild-type and mutant
epidermis at any developmental stage (Supplementary
Figure S1 online).
We also performed ultrahigh-pressure liquid chromato-
graphy/MS/MS analyses to determine the relative amount of
cholesterol and fatty acids. Levels of cholesterol and choles-
terol-3-sulfate were significantly reduced in the epidermis of
Ctip2 / mice at E16.5 but were unaltered at all later time
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points (Supplementary Figure S2a and b online). Although the
amount of palmitic acid and stearic acid was similar between
wild-type and null skin at E16.5–E18.5, their levels doubled
in the P0 Ctip2 / epidermis compared with the wild-type
epidermis (Supplementary Figure S2c and d online). All
together, our results indicate that epidermal lipid composition
is altered in the absence of transcriptional regulator Ctip2.
Ctip2 directly regulates the expression of a subset of genes
involved in lipid metabolism during skin development
Previous studies have identified four major pathways involved
in CER synthesis: the de novo pathway, the salvage pathway,
the sphingomyelinase pathway, and the exogenous CER-
recycling pathway (Kitatani et al., 2008; Mizutani et al.,
2009). We hypothesized that altered sphingolipid profiles in
 Saturated 
ce
ra
m
ides
E16.5 E17.5 E18.5 P0
 
 
 
 Saturated 
sphingom
yelins
 Unsaturated 
ce
ra
m
ides
14 16 18 20 22 24 26 28
0
50
100
150
200 WT
Ctip2–/–
WT
Ctip2–/–
WT
Ctip2–/–
WT
Ctip2–/–
WT
Ctip2–/–
WT
Ctip2–/–
WT
Ctip2–/–
WT
Ctip2–/–
WT
Ctip2–/–
WT
Ctip2–/–
WT
Ctip2–/–
WT
Ctip2–/–
WT
Ctip2–/–
WT
Ctip2–/–
WT
Ctip2–/–
WT
Ctip2–/–
* *
N-acyl chain length
N-acyl chain length
N-acyl chain length N-acyl chain length N-acyl chain length N-acyl chain length
N-acyl chain length N-acyl chain length N-acyl chain length N-acyl chain length
N-acyl chain length N-acyl chain length N-acyl chain length
N-acyl chain length N-acyl chain length N-acyl chain length
Ce
ra
m
id
e 
co
nt
en
t
(pm
ol 
pe
r m
g s
kin
)
Ce
ra
m
id
e 
co
nt
en
t
(pm
ol 
pe
r m
g s
kin
)
Ce
ra
m
id
e 
co
nt
en
t
(pm
ol 
pe
r m
g s
kin
)
Ce
ra
m
id
e 
co
nt
en
t
(pm
ol 
pe
r m
g s
kin
)
Ce
ra
m
id
e 
co
nt
en
t
(pm
ol 
pe
r m
g s
kin
)
Ce
ra
m
id
e 
co
nt
en
t
(pm
ol 
pe
r m
g s
kin
)
Ce
ra
m
id
e 
co
nt
en
t
(pm
ol 
pe
r m
g s
kin
)
Ce
ra
m
id
e 
co
nt
en
t
(pm
ol 
pe
r m
g s
kin
)
14 16 18 20 22 24 26 28
0
500
1,000
1,500
*
*
Sp
hi
ng
om
ye
lin
 c
on
te
nt
(pm
ol 
pe
r m
g s
kin
)
Sp
hi
ng
om
ye
lin
 c
on
te
nt
(pm
ol 
pe
r m
g s
kin
)
Sp
hi
ng
om
ye
lin
 c
on
te
nt
(pm
ol 
pe
r m
g s
kin
)
Sp
hi
ng
om
ye
lin
 c
on
te
nt
(pm
ol 
pe
r m
g s
kin
)
Sp
hi
ng
om
ye
lin
 c
on
te
nt
(pm
ol 
pe
r m
g s
kin
)
Sp
hi
ng
om
ye
lin
 c
on
te
nt
(pm
ol 
pe
r m
g s
kin
)
Sp
hi
ng
om
ye
lin
 c
on
te
nt
(pm
ol 
pe
r m
g s
kin
)
Sp
hi
ng
om
ye
lin
 c
on
te
nt
(pm
ol 
pe
r m
g s
kin
)
14
:1
16
:1
18
:1
20
:1
22
:1
24
:1
26
:1
28
:1
0
5
10
15
*
14
:1
16
:1
18
:1
20
:1
22
:1
24
:1
26
:1
28
:1
0
100
200
300
400
* **
*
14 16 18 20 22 24 26 28
0
50
100
150
200
250
14 16 18 20 22 24 26 28
0
50
100
150
200
250
*
14
:1
16
:1
18
:1
20
:1
22
:1
24
:1
26
:1
28
:1
0
5
10
15
14
:1
16
:1
18
:1
20
:1
22
:1
24
:1
26
:1
28
:1
0
20
40
60
80
100
**
14 16 18 20 22 24 26 28
0
50
100
150
14 16 18 20 22 24 26 28
0
20
40
60
**
**
*
*
14
:1
16
:1
18
:1
20
:1
22
:1
24
:1
26
:1
28
:1
0
5
10
15
14
:1
16
:1
18
:1
20
:1
22
:1
24
:1
26
:1
28
:1
0
2
4
6
***
*
14 16 18 20 22 24 26 28
0
50
100
150
*
*
14 16 18 20 22 24 26 28
0
50
100
150
14
:1
16
:1
18
:1
20
:1
22
:1
24
:1
26
:1
28
:1
0
10
20
30
40
14
:1
16
:1
18
:1
20
:1
22
:1
24
:1
26
:1
28
:1
0
5
10
15
 
 
 Unsaturated 
sphingom
yelins
a b c d
e f g h
i j k l
m n o p
Figure 1. Liquid chromatography–tandem mass spectrometry (LC/MS/MS) analyses of mouse epidermal sphingolipids during skin development. The epidermal
sphingolipids were extracted from the skin of E16.5, E17.5, and E18.5 embryos and from that of P0 wild-type (WT) and Ctip2 / mice. The amount of
saturated and unsaturated ceramides and sphingomyelins was determined according to their N-acyl chain length using LC/MS/MS analyses. The absolute
content of (a–d) saturated and (e–h) unsaturated ceramides at (a, e) E16.5, (b, f) E17.5, (c, g) E18.5, and (d, h) P0 was quantified using saturated and unsaturated
ceramide standards and expressed as pmol per mg of skin (for details see Materials and Methods). The amount of (i–l) saturated and (m–p) unsaturated
sphingomyelin was also determined at different developmental stages, namely, (i, m) E16.5, (j, n) E17.5, (k, o) E18.5, and (l, p) P0, using saturated and unsaturated
sphingomyelin standards and expressed as pmol per mg of skin (see Materials and Methods). Statistical analyses were performed by Student’s unpaired t-test using
Graphpad Prism software. *Po0.05; **Po0.005, ***Po0.001. Data were reported as mean±SEM (n¼ 9). The results represent three separate experiments
conducted in triplicate. E, embryonic day; P, postnatal day.
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mutant mice could be because of altered expression of genes
encoding proteins involved in the sphingolipid metabolism.
To test this hypothesis, we evaluated the expression of genes
involved in the different CER biosynthesis pathways by qRT-
PCR analyses in wild-type control and mutant skin (for details
see Materials and Methods). Expressions of CER synthase 3
(Lass3) and palmitoyltransferases (Sptlc1 and Sptlc3) were
downregulated at E16.5 and E17.5, whereas CER synthases
Lass1 and Lass2 were significantly reduced at E18.5 in
Ctip2 / skin (Figure 2a–c). Lass6 was consistently down-
regulated from E16.5 to E18.5 in mutant skin (Figure 2a–c).
Thus, genes encoding enzymes in the de novo pathway were
altered after ablation of Ctip2. Similarly, transcript levels of
enzymes involved in the sphingomyelinase pathway, such as
sphingomyelinases (Smpd1 and Smpd2), were significantly
downregulated at E18.5, whereas sphingomyelin synthase
(Sgms2) level was upregulated at E16.5 in null embryos
compared with the wild-type ones (Figure 2d–f). Expression
of glucosylceramide synthase (Ugcg), which turns complex
sphingolipids into glucosylcerarimde, was also reduced at
E18.5, whereas acid beta-glucosidase (Gba2), which is
involved in the salvage pathway, was downregulated in the
skin of null mice from E16.5 to E18.5 (Figure 2d–f). Cerami-
dases are involved in the breaking down of short-chain
CER, facilitating its conversion to sphingosine. In particular,
the reduced expression of neutral ceramidase 2 (Asah2) and
alkaline ceramidase 1 (Acer1) was observed at all develop-
mental stages in the mutant epidermis (Figure 2g–i). Levels of
all other members of acid ceramidases (Asah1 and Asah3) and
alkaline ceramidases (Acer2 and Acer3) were unaltered in the
mutants at all stages of development (Figure 2g–i). Similarly,
sphingosine kinases (Sphk1 and Sphk2) are responsible for the
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Figure 2. COUP-TF-interacting protein 2 (Ctip2) regulates the expression of genes encoding lipid-metabolizing enzymes during skin development. Expression
of (a–c) ceramide synthases (Lass1–Lass3, Lass6), serine palmitoyltransferases (Sptlc1, Sptlc3); (d–f) sphingomyeinases (Smpd1, Smpd2), sphingomyelin
synthase 2 (Sgms2), glucosylceramide synthase (Ugcg), and acid beta-glucosidase (Gba2); (g–i) N-acylsphingosine amidohydrolases (acid and neutral
ceramidases: Asah1, Asah2), sphingosine kinases (Sphk1, Sphk2), and alkaline ceramidases (Acer1, Acer2) was analyzed by quantitative real-time reverse-
transcriptase PCR using specific primers indicated in Supplementary Table S1 online. All values represent the relative transcript level after normalization
with Gapdh transcripts. Statistical analyses were performed by Student’s unpaired t-test using Graphpad Prism software. *Po0.05; **Po0.005. Data were
reported as mean±SEM (n¼ 9). The results represent three separate experiments conducted in triplicate. E, embryonic day.
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disposal of sphingosine to sphingosine-1-phosphate, the
expression level of which was reduced at E16.5 in the mutant
epidermis (Figure 2g). No significant changes in the relative
mRNA levels of several other enzymes involved in CER
synthesis pathways were observed between wild-type and
Ctip2 / embryonic skin (Supplementary Figure S3a–c
online). Furthermore, protein levels of Lass2, Gba2, and
epidermis-type lipoxygenase 3 (eLox3) were significantly
reduced in Ctip2-null skin compared with wild-type skin
at E18.5 (Figure 3a and b) (Golonzhka et al., 2008). Taken
together, our results indicate that the expression of a subset
of genes encoding enzymes involved in the sphingolipid
biosynthesis pathways was altered during skin organogenesis
in the absence of Ctip2.
To investigate whether some of the lipid-metabolizing
genes, which are dysregulated in mutant skin, are direct
targets of transcriptional regulator Ctip2, we conducted
in vivo ChIP assay on neonatal (P0) mouse epidermal keratino-
cyte extracts. The promoter regions of several genes encoding
lipid-metabolizing enzymes such as Lass1-3, 6, Sptlc1-3,
Smpd1-2, Ugcg, Gba2, and eLox3 (Golonzhka et al., 2008),
the expressions of which were altered in Ctip2 / skin, were
selected and primers were designed to determine possible
Ctip2 binding within 6 kb upstream of transcription starting
sites. Our results confirmed that Ctip2 was recruited within the
 1 kb promoter region of Lass2, Gba2, and eLox3, as well as
between the 5 and 6 kb promoter region of eLox3 relative to
transcription starting sites (Figure 4a–c). However, we did not
observe the direct recruitment of Ctip2 to the promoter regions
of several other lipid-metabolizing genes (Supplementary
Figure S4a–k online). Our results indicate that Lass2, Gba2,
and eLox3 are possible direct targets of Ctip2 in the regulation
of skin lipid metabolism. All together, the results suggest that
Ctip2 directly or indirectly regulates expression of a subset of
lipid-metabolizing genes and controls epidermal sphingolipid
biosynthesis during skin organogenesis.
DISCUSSION
The establishment of an effective physical barrier protecting
the living organism from its surrounding environment is the
key function of mammalian skin (Hoffjan and Stemmler,
2007). The transport of most substances across the SC takes
place through the lipid bilayer, suggesting its essential role
in the epidermal barrier function (Jungersted et al., 2008).
The major SC lipids, CERs, cholesterol, and fatty acids, have
distinct roles in maintaining normal barrier functions (Elias and
Menon, 1991; Ishikawa et al., 2010). CERs and cholesterol
were shown to have an influence on (and are influenced by)
the integrity of the SC, whereas free fatty acids have a major
role in lipid bilayer formation and pH maintenance (Baroni
et al., 2012). We have identified Ctip2 as a key regulator
of skin lipid metabolism, which has an important role in the
establishment of EPB during development. Ablation of Ctip2
leads to altered lipid composition in the developing mouse
epidermis, such as reduced CER at E17.5–P0 as well as
increased sphingomyelins at E16.5–E18.5. Ctip2 regulates
sphingolipid homeostasis in mouse embryonic skin by
modulating the expression of several key enzymes involved
in lipid metabolism. Here we demonstrate that the
transcription factor Ctip2 is recruited to the promoter regions
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Figure 3. Immunoblot analyses of lipid-metabolizing enzymes in the
developing murine epidermis. (a) Western blot analyses were performed on
protein extracted from embryonic day 18.5 wild-type (WT) and Ctip2 /
mouse epidermis to study the expression levels of eLox3, Gba2, and Lass2
using specific antibodies. b-Actin was used as an internal control. (b) Protein
levels of eLox3, Gba2, and Lass2 were quantified in wild-type and mutant
epidermis by densitometry analyses of western blots. All data were normalized
by the corresponding b-actin levels. Statistical analyses were performed by
Student’s unpaired t-test using Graphpad Prism software. *Po0.05. Data were
reported as mean±SEM (n¼ 9). The results represent three separate
experiments conducted in triplicate. KO, knockout.
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Figure 4. Chromatin immunoprecipitation (ChIP) analyses on murine keratinocytes for lipid-metabolizing genes. ChIP assay was performed on freshly
isolated neonatal mouse epidermal keratinocytes using anti-COUP-TF-interacting protein 2 (anti-Ctip2) antibody and the results were analyzed by quantitative
reverse transcriptase in real time using primers indicated in Supplementary Table S2 online. Rat Gig was used as the control. Ctip2 was recruited to the
promoter (relative to transcription start site) regions of (a) Lass2, (b) Gba2, and (c) eLox3. Statistical analyses were performed by Student’s unpaired t-test using
Graphpad Prism software. *Po0.05; **Po0.005. The results represent three separate experiments conducted in triplicate. 30-UTR, untranslated region.
Z Wang et al.
Ctip2 Regulates Epidermal Lipid Metabolism
672 Journal of Investigative Dermatology (2013), Volume 133
of a subset of genes (elox3, Lass2, and Gba2) involved in the
sphingolipid biosynthesis pathways and could directly
regulate their expression (Supplementary Figure S5 online).
Skin barrier defects are caused not only by altered levels
of protein(s) involved in keratinocyte terminal differentia-
tion, cross-linking of cornified envelopes, and formation of
intercellular junctions but also by impaired formation and
maintenance of skin lipid barrier (Furuse et al., 2002;
Kirschner and Brandner, 2012). Previous studies have
shown that Ctip2 regulates keratinocyte proliferation and
late terminal differentiation in a cell-autonomous manner;
the ultrastructural analyses of the epidermis have revealed
defects in lipid disc formation, loosely packed corneocytes,
and disorganized intercellular lamellar body membranes in
Ctip2-null mice (Golonzhka et al., 2008 and unpublished
data). In this study, we have focused on the role of Ctip2 in
controlling the epidermal lipid barrier by modulating lipid
metabolism. Herein we have applied a mass spectro-
metry method to systemically detect and profile CERs,
sphingomyelins, sphingosines, and sphinganines simultane-
ously in murine epidermis. As a crucial member of SC lipids,
there are few reports on the profiling of skin sphingomyelins.
Our present data confirm deregulated levels of both long-
chain and very long-chain saturated and unsaturated CERs in
the mutant epidermis at different stages of skin development.
Along the same line, the overall levels of long-chain and
very long-chain saturated and unsaturated sphingomyelins
were significantly enhanced in the mutants at all stages
analyzed. In the present study, we have specifically looked
at CER [NS] containing nonhydroxy fatty acids (N) and
sphingosines (S) but were unable to conduct mass
spectrometry studies on other subclasses containing (N)
and phytosphingosines (P)-[NP]; (N) and 6-hydroxy sphin-
gosines (H)-[NH]; hydroxy fatty acids (A) and sphingosines
(S)-[AS]; [AP]; [AH]; ester-linked fatty acids (E), hydroxy fatty
acids (O), and (S)-[EOS]; and [EOP] and [EOH] because of
the lack of available deuterated CER internal standards for
each subclass. Additional analyses for the different
subclasses will be performed in future using a specific
internal standard for each subclass.
Our results indicate that the altered expressions of CER
synthases 1–6 (Lass 1–6), sphingomyelinases (Smpd1 and
Smpd2), glucosylceramide synthase (Ugcg), and that of acid
beta-glucosidase (Gba2) at different developmental stages
of Ctip2-null skin contribute to an overall decrease in the
epidermal CER levels in mutant embryonic skin. It was also
shown that several ceramidases involved in CER metabolism
(Asah2 and Acer1) are reduced in Ctip2 / skin. As CER
biosynthesis is a complex process regulated by multiple
pathways, it is still unclear which pathway contributes most
to the reduction of epidermal CER content in the ablation
of Ctip2. Lass 1–6 have been reported to be involved in
UVB-induced apoptosis and their expression was increased
after UVB irradiation in normal human keratinocytes but was
reduced in aged skin (Uchida et al., 2003; Jensen et al., 2005).
A recent study has reported that Lass3-mutant mice die after
birth because of increased skin barrier defects, characterized
by increased transepidermal water loss, loss of ultra-long-chain
CERs, and nonfunctional cornified envelopes (Jennemann
et al., 2012). The upregulation of Sgms2 and the reduced
expression of Smpd1 and Smpd2 in Ctip2 / mice may
partially account for the increased amount of sphingomyelins
observed at later stages in mutant skin (Figure 1j
and k). Furthermore, loss of Gba2, the expression of which
is altered in the mutant epidermis, has been reported to
lead to barrier defects in patients with Gaucher’s disease
(Holleran et al., 1994). Similarly, eLox3 and its substrate
12R-lipoxygenase (12R-LOX) are involved in the formation
of oxidized CERs in mouse epidermis; 12R-LOX-deficient mice
die shortly after birth because of severe barrier abnormalities
with the absence of protein-bound EOS CER (Zheng et al.,
2011). Interestingly, we have reported earlier that eLox3
expression is downregulated in Ctip2 / embryonic skin
(Golonzhka et al., 2008). Here we have furthered our studies
and have shown that Ctip2 could directly regulate the
expressions of eLox3, Gba2, and Lass2 in mouse embryonic
skin by recruitment to their promoter regions. In addition, the
catabolism and metabolism of sphingosines were both
downregulated in Ctip2 / epidermis, which may explain
the consistency of its amount between wild-type and
null mouse epidermis. All together, we have identified Ctip2
as a key regulator of several lipid-metabolizing genes and
hence of epidermal sphingolipid biosynthesis during skin
development.
Sphingolipids are key components in skin barrier home-
ostasis, as well as in other cellular processes such as cell cycle
arrest, apoptosis, and stress responses (Hannun, 1996;
Ogretmen and Hannun, 2004). CER is a central metabolite,
whose biosynthesis is regulated at multiple levels with spatial
separation of enzymes involved in CER formation (Futerman
and Riezman, 2005; Kitatani et al., 2008). It remains unclear
whether alteration of the enzymes in one of the pathways
could have an effect on other pathways and finally modulate
the biological functions. It would be interesting to systemically
compare the lipid composition in healthy subjects with that of
patients with skin disorders, such as atopic dermatitis and
psoriasis. It is possible that, besides Ctip2, other regulatory
pathways are also involved in controlling CER biosynthesis.
B-cell lymphoma/leukemia 11A (Bcl11a/Ctip1) protein is a
homolog of Ctip2, which was found to be upregulated in
Ctip2-null mice at E18.5 (Golonzhka et al., 2008). The role
of Ctip1 in epidermal barrier development and maintenance is
still unclear. Further investigation on the expression pattern
and distribution of Ctip1, as well as its role in lipid barrier
homeostasis in mouse epidermis, will be performed using
Ctip1 / mice.
MATERIALS AND METHODS
Mice
The floxed Citp2 allele was generated by flanking exon 4 of the Ctip2
locus, which encodes for three-fourths of the open reading frame
(Golonzhka et al., 2008). Ctip2-null (Ctip2 / ) mice were generated
by breeding mice containing the floxed Ctip2 allele with
cytomegalovirus promoter–driven Cre recombinase transgenic mice
(Golonzhka et al., 2008). OSU IACUC approval was obtained for
animal experiments.
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Lipid extraction
Fetus from E16.5 to E18.5 and neonatal mice were collected and
genotyped (Golonzhka et al., 2008). A minimum of three wild-type
and Ctip2 / fetuses were taken from the same litter and compared
between littermates. A minimum of three litters were analyzed
from each developmental stages. Skin was isolated, weighed, and
incubated overnight in CnT-07 medium (CELLnTEC, Bern,
Switzerland) containing 1 mg ml 1 dispase (Gibco, Grand Island,
NY) at 4 1C to dissociate the epidermis.
Raw skin lipid was extracted using the Bligh and Dyer method
(Folch et al., 1957; Bligh and Dyer, 1959). Briefly, skin epidermis was
incubated in extraction solvent (chloroform:methanol:water (1:2:0.8),
10–15 mg tissue per 1 ml extraction solvent) overnight at room
temperature. Fresh extraction solvent was added to epidermis
samples on the second day and the old extraction solvent was saved.
Samples were sonicated for five cycles, for 30 seconds each, and the
suspension was shaken for 30 minutes at room temperature. After
centrifugation at 2,000 r.p.m. for 10 minutes, the pellets were dis-
carded and the extraction solvents were combined. Chloroform and
water were added to the extraction solvent at an extraction solvent:-
chloroform:water ratio of 7.6:2:2. After mixing and centrifuging,
the upper phase was discarded and the lower phase (chloroform)
was washed twice with chloroform:methanol:water at a ratio of
1:1:0.9. The lower phase was dried in nitrogen, weighed, and stored
at  20 1C.
Liquid chromatography–tandem mass spectrometry
Raw skin lipid was further purified as in previous reports
(Merrilljr et al., 2005; Monette et al., 2011). A volume of 10ml of
sphingolipid internal standard mixture (Avanti, Alabaster, Alabama)
and 1 mg of raw lipid were added to 1.5 ml of chloroform:methanol
(1:2) and sonicated in the bath sonicator for 30 seconds. After
2 hours of incubation at 48 1C, the samples were cooled on ice.
Samples were then incubated for 1 hour at 37 1C with 75ml of 1 M
KOH in methanol to remove the free fatty acids and triacylglycerol
and cooled on ice. A volume of 12ml of glacial acetic acid was added
to neutralize the pH. Phase separation was achieved by adding 2 ml
of chloroform and 4 ml of water, and samples were gently vortexed.
After centrifugation for 15 minutes at 2000 r.c.f., the chloroform
layer was aspirated and dried under nitrogen. The samples were
reconstituted in 200ml of chloroform:methanol (3:1) and diluted 1:4
with acetonitrile:methanol:acetic acid (97:2:1) with 5 mM ammonium
acetate.
LC/MS/MS was performed and relative quantification was based on
skin weight and sphingolipid standards (Monette et al., 2011). In brief,
lipids were separated by HPLC using a Supelco Discovery column
(2 mm 50 mm; Sigma-Aldrich, St Louis, MD) at a flow rate of
300ml min 1. Mobile phase A consisting of methanol:water (60:40)
and mobile phase B consisting of methanol:chloroform (60:40) both
contained 0.2% (v/v) formic acid and 10 mM ammonium acetate. The
column was pre-equilibrated at 100% phase A and 5-ml sample was
injected; 100% mobile phase A was maintained for 1 min, followed
by a linear increase to 40% mobile phase B in 7 minutes. This was
followed by a linear increase to 70% mobile phase B in the next
6 minutes, which was maintained for the remainder (6 minutes) of the
20 minute run.
Sample detection was performed using a triple-quadrupole mass
spectrometer operated in positive mode (Applied Biosystems/
MDS Sciex, Carlsbad, CA, API300) with multiple reaction monitoring.
The results represent three separate experiments conducted in
triplicate.
Ultrahigh-pressure liquid chromatography/MS/MS
Ultrahigh-pressure liquid chromatography was performed on a
Shimadzu Nexera system (Shimadzu, Columbia, MD) coupled with
a hybrid quadrupole time-of-flight mass spectrometer (TripleTOF
5600, Applied Biosystems/MDS Sciex) with raw skin lipids. Chroma-
tographic separations were carried out on a Brownlee Analytical C18
column (50 2.1 mm, 1.9mm; PerkinElmer, Boston, MA). The flow
rate was 0.35 ml min  1 and mobile phases consisted of water (A) and
acetonitrile (B), both with 0.1% formic acid. The elution gradient was
as follows: 0 minutes, 25% B; 2 minutes, 55% B; 7 minutes, 100% B;
and 9 minutes, 100% B. The column was equilibrated 3 minutes
before each injection. Column temperature was held at 40 1C and the
injection volume was 3ml.
Mass spectrometry was performed on an AB SCIEX TripleTOF 5600
equipped with an electrospray ionization source. The instrument was
operated in information-dependent MS/MS acquisition mode with
the collision energy set at 30 V and a collision energy spread of 10 V.
TOF MS acquisition time was 0.15 seconds and MS/MS acquisition
time was 0.10 seconds. Scan range was 70–1000m/z for TOF MS
and 40–1000m/z for MS/MS. Ion source gas 1 and 2 and curtain gas
(all nitrogen) were set at 50 and 40 and 25, respectively. Source
temperature was set at 500 1C and IonSpray voltage at 5.5/ 5.5 kV.
A set of standards was run periodically throughout the batch to assess
system variance and stability. The instrument was automatically
calibrated every five runs.
Stearic acid, palmitic acid, cholesterol, and cholesterol-3-sulfate
were identified using authentic standards with accurate mass measure-
ments, isotope distribution, MS/MS fragmentation, and retention time.
The results represent three separate experiments conducted in triplicate.
Absolute quantification
Absolute quantification of epidermal CERs, sphingomyelin, sphingo-
sine, and sphinganine was on the basis of comparison with a
synthetic sphingolipid standard mixture as previously described
(Monette et al., 2010). In brief, 10 synthetic compounds were
obtained (Avanti): sphinganine C18 (860498P), sphingosine C18
(860490P), CER C16:0 (860516P), CER C22:0 (860510P), CER
C18:1 (860519C), CER C24:1 (860525C), sphingomyelin C18:0
(860586P), sphingomyelin C18:1 (860587C), sphingomyelin C24:0
(860592P), and sphingomyelin C24:1 (860593P). Standard solutions
were prepared, and the amount of analyte was determined on the
basis of comparison of the peak area of the analyte with that of the
sphingolipid. The results represent three separate experiments
conducted in triplicate.
Quantitative real-time reverse-transcriptase PCR
RNA was extracted and cDNA was synthesized from the skin of
mouse fetuses and neonates (Indra et al., 2005b; Wang et al., 2011).
Real-time PCR was performed on an ABI 7500 Real-Time PCR system
using SYBR green methodology (Applied Biosystems) (Indra et al.,
2005a, 2005b). Relative gene expression analysis of the qRT-PCR
data was performed using Gapdh as an internal control, and the delta-
delta CT method was used for quantification as previously described
(Wang et al., 2011). All qRT-PCR primers are indicated in
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Supplementary Table S1 online. The results represent three separate
experiments conducted in triplicate.
Western blotting
Protein was extracted from mouse epidermis, and western blotting
was performed according to previous reports using specific antibodies
against Lass2 (1:500), Gba2 (1:1, 000), and eLox3 (1:2, 000) (Wang
et al., 2011; Santa Cruz Biotechnology, Santa Cruz, CA). Western
blotting represents the results from three separate experiments
conducted in triplicate.
Chromatin immunoprecipitation
ChIP assay was performed according to Hyter et al., 2010. ChIP DNA
was amplified using an ABI-7500 Real-time PCR machine with
specific primers indicated in Supplementary Table S2 online. The
results represent three separate experiments conducted in triplicate.
Statistics
Statistical significance of differences between groups was analyzed
using GraphPad Prism software (Graphpad Software, La Jolla, CA)
using Student’s unpaired t-test. All statistical analyses were performed
in a double-blinded manner.
The following CER code is used according to previous reports
(Motta et al., 1993; Robson et al., 1994): Ceramide EOS (or ceramide
1), ceramide containing ester-linked fatty acids (E), -hydroxy fatty
acids (O), and sphingosines (S); Ceramide NS (or ceramide 2),
ceramide containing nonhydroxy fatty acids (N) and sphingosines
(S); Ceramide NP (or ceramide 3), ceramide containing nonhydroxy
fatty acids (N) and phytosphingosines (P); Ceramide EOH (or
ceramide 4), ceramide containing ester-linked fatty acids (E),
-hydroxy fatty acids (O), and 6-hydroxy sphingosines (H); Ceramide
AS (or ceramide 5), ceramide containing -hydroxy fatty acids (A) and
sphingosines (S); Ceramide AP (or ceramide 6), ceramide containing
hydroxy fatty acids (A) and phytosphingosines (P); Ceramide AH (or
ceramide 7), ceramide containing hydroxy fatty acids (A) and 6-
hydroxy sphingosines (H); Ceramide NH, ceramide containing
nonhydroxy fatty acids (N) and 6-hydroxy sphingosines (H);
Ceramide EOP (or ceramide 9), CER containing ester-linked fatty
acids (E), hydroxy fatty acids (O), and phytosphingosines (P).
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